Environmental services provider Montrose (NYSE:MEG) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 25.9% year on year to $224.9 million. The company’s full-year revenue guidance of $820 million at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $0.36 per share was 11.6% above analysts’ consensus estimates.
Is now the time to buy MEG? Find out in our full research report (it’s free for active Edge members).
Montrose (MEG) Q3 CY2025 Highlights:
- Revenue: $224.9 million vs analyst estimates of $202.8 million (25.9% year-on-year growth, 10.9% beat)
- Adjusted EPS: $0.36 vs analyst estimates of $0.32 (11.6% beat)
- Adjusted EBITDA: $33.66 million vs analyst estimates of $28.92 million (15% margin, 16.4% beat)
- The company slightly lifted its revenue guidance for the full year to $820 million at the midpoint from $815 million
- EBITDA guidance for the full year is $115 million at the midpoint, in line with analyst expectations
- Operating Margin: 4.4%, up from -0.6% in the same quarter last year
- Market Capitalization: $869.9 million
StockStory’s Take
Montrose’s third quarter was marked by strong organic growth across all segments and a decisive expansion in margins, leading to a positive market response. Management attributed the results to robust demand from industrial clients, notable cross-selling following emergency response projects, and substantial progress in water treatment offerings. CEO Vijay Manthripragada emphasized the beneficial impact of advanced monitoring technologies and highlighted how recent regulatory changes at the state and international levels have created sustained demand for Montrose’s environmental services. He noted, “Our financial results speak to how environmental stewardship can work in concert with development and value creation.”
Looking ahead, Montrose’s updated guidance is anchored by ongoing investments in sales, marketing, and technology, as well as a focus on scalable profitability. Management expressed confidence that momentum in the water treatment business, the wind-down of underperforming renewables, and continued regulatory activity will support growth into 2026. CFO Allan Dicks discussed initiatives to further improve cash flow and leverage, stating, “We are investing in marketing to boost our brand equity, rewarding employees for their contributions, refining our go-to-market strategy and assessing future organizational needs.” The company expects that a restart of acquisitions next year will supplement organic growth and margin expansion.
Key Insights from Management’s Remarks
Management credited the quarter’s performance to cross-selling after major emergency response projects, growth in core consulting and water treatment, and margin improvement from operating leverage.
-
Emergency response cross-selling: Revenue growth benefited from downstream consulting, testing, and remediation business won after emergency response events. Management explained that these projects not only drove one-time sales but also set up recurring and long-term opportunities across segments.
-
Water treatment momentum: The water treatment business saw strong organic growth and improved margins, supported by new regulations on per- and polyfluoroalkyl substances (PFAS) and demand from industries such as pharmaceuticals and semiconductors. Management noted, “Our optimism is higher... this is not just a PFAS play, but that is certainly a driver of the business.”
-
Measurement and Analysis margin gains: The Measurement and Analysis segment achieved record organic growth and margin expansion, driven by increased utilization and efficiency improvements in laboratory and field services. Segment margins are expected to remain above 20% in future years.
-
Renewables wind-down: The company is exiting its renewables service line within the Remediation and Reuse segment, citing policy uncertainty and lower internal returns. The wind-down reduced segment margins this quarter, but management expects overall segment margins to rise as the water treatment business becomes a larger portion of revenue.
-
International and industrial demand: Montrose benefited from increased mining activity in Canada and Australia and higher demand tied to stricter EU methane regulations, which impact U.S. energy exporters. These trends, combined with state-level environmental rules in the U.S., offset federal policy fluctuations.
Drivers of Future Performance
Montrose’s outlook is shaped by regulatory-driven demand, investments in commercial talent, and a renewed focus on scalable profitability.
-
Regulatory and market tailwinds: Management expects continued growth from tightening state and international regulations, especially for air emissions and water contaminants. The company highlighted that multiyear regulatory cycles create predictable demand, and that recent EU methane rules and U.S. state policies are expanding the addressable market for its services.
-
Margin expansion from business mix: The exit from renewables and the scaling of water treatment operations are expected to drive margin improvement. Management anticipates the water treatment business will achieve margins near 20%, supporting overall profitability as it becomes a larger share of the Remediation and Reuse segment.
-
Acquisition strategy restart: With balance sheet improvements and cash flow gains, Montrose plans to restart acquisitions in 2026, targeting both capability and geographic reach. Management believes this will supplement organic growth and allow further expansion in international and high-demand end markets.
Catalysts in Upcoming Quarters
In the coming quarters, the StockStory team will focus on (1) the pace of margin improvement as the renewables business is fully wound down and water treatment expands, (2) progress in cross-selling and recurring work following large emergency response projects, and (3) the timing and scale of new acquisitions as Montrose prepares to restart its M&A program. Continued regulatory activity and state-driven demand shifts will also be important indicators to watch.
Montrose currently trades at $26.40, up from $24.57 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free for active Edge members).
Stocks That Trumped Tariffs
Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.
The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.